CAPRICOR THERAPEUTICS INC's ticker is CAPR and the CUSIP is 14070B309. A total of 26 filers reported holding CAPRICOR THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $618,254 | -24.3% | 129,613 | +7.7% | 0.00% | – |
Q1 2024 | $816,933 | +31.3% | 120,314 | -5.4% | 0.00% | – |
Q4 2023 | $622,150 | +73.3% | 127,229 | +21.2% | 0.00% | – |
Q3 2023 | $358,963 | -28.8% | 104,960 | -0.5% | 0.00% | – |
Q2 2023 | $504,324 | +12.8% | 105,507 | -0.4% | 0.00% | – |
Q1 2023 | $447,211 | +10.5% | 105,974 | +1.1% | 0.00% | – |
Q4 2022 | $404,563 | -35.9% | 104,809 | -0.5% | 0.00% | – |
Q3 2022 | $631,000 | +78.2% | 105,305 | +3.9% | 0.00% | – |
Q2 2022 | $354,000 | +0.9% | 101,400 | -1.0% | 0.00% | – |
Q1 2022 | $351,000 | +15.5% | 102,421 | -1.4% | 0.00% | – |
Q4 2021 | $304,000 | -27.8% | 103,923 | -0.7% | 0.00% | – |
Q3 2021 | $421,000 | -21.3% | 104,672 | +0.4% | 0.00% | – |
Q2 2021 | $535,000 | +18.1% | 104,251 | +7.5% | 0.00% | – |
Q1 2021 | $453,000 | -3.4% | 96,941 | -29.1% | 0.00% | – |
Q4 2020 | $469,000 | -41.0% | 136,814 | -9.6% | 0.00% | – |
Q3 2020 | $795,000 | +16.4% | 151,365 | +1.9% | 0.00% | – |
Q2 2020 | $683,000 | – | 148,471 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coastal Bridge Advisors, LLC | 10,894 | $42,051 | 0.01% |
Jump Financial, LLC | 14,595 | $56,337 | 0.00% |
HAP Trading, LLC | 12,700 | $8 | 0.00% |
Cubist Systematic Strategies, LLC | 29,387 | $113,434 | 0.00% |
Tower Research Capital LLC (TRC) | 3,674 | $14 | 0.00% |
Cutler Group LLC / CA | 3,021 | $11 | 0.00% |
WELLS FARGO & COMPANY/MN | 172 | $664 | 0.00% |
NORTHERN TRUST CORP | 104,809 | $404,563 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GOLDMAN SACHS GROUP INC | 24,594 | $94,933 | 0.00% |